<DOC>
	<DOC>NCT02035709</DOC>
	<brief_summary>Treatment of postoperative pain with hydromorphone (a strong analgesic) using patient-controlled analgesia with target concentrations in blood compared to conventional patient-controlled analgesia after planed cardiac surgery</brief_summary>
	<brief_title>Postoperative Pain Therapy With Hydromorphone Using TCI-PCA</brief_title>
	<detailed_description />
	<mesh_term>Pain, Postoperative</mesh_term>
	<mesh_term>Hydromorphone</mesh_term>
	<criteria>Written informed consent Age between 40 and 85 years, both genders Scheduled for elective cardiac surgery involving thoracotomy and subsequent ICU stay Administration of other analgesics or sedatives, if not administered in stable dosage for at least 14 days or if not used for premedication and surgery Administration of hydromorphone in the period between screening and surgery Severe hepatic or renal impairment in medical history BMI ≥35 kg/m² ASA ≥4</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Therapy</keyword>
</DOC>